Inducible hydrogen sulfide synthesis in chondrocytes and mesenchymal progenitor cells: Is H2S a novel cytoprotective mediator in the inflamed joint?

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 4, 2012, Pages 896-910

  Fox, Bridget ^a   Schantz, Jan Thorsten ^b,c   Haigh, Richard ^a,d   Wood, Mark E ^a   Moore, Phillip K ^e   Viner, Nick ^a,f   Spencer, Jeremy P E ^g   Winyard, Paul G ^a   Whiteman, Matthew ^a,e  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f TORBAY HOSPITAL   (United Kingdom)

^g UNIVERSITY OF READING   (United Kingdom)

Author keywords

Apoptosis; Arthritis; Cystathionine, lyase; Cystathionine synthase; Gyy4137; Oxidative stress

Indexed keywords

HYDROGEN SULFIDE;

ARTHRITIS; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL PROTECTION; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; PATHOLOGY;

ARTHRITIS; CELLS, CULTURED; CHONDROCYTES; CYTOPROTECTION; HUMANS; HYDROGEN SULFIDE; MESENCHYMAL STEM CELLS;

EID: 84864465234     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01357.x     Document Type: Article

References (80)

1. Li L, Rose P, Moore PK. Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol. 2011; 51: 169-87.
2. Whiteman M, Moore PK. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability? J Cell Mol Med. 2009; 13: 488-507.
3. Whiteman M, Winyard PG. Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Expert Rev Clin Pharmacol. 2011; 4: 13-32.
4. Zhi L, Ang AD, Zhang H, et al. Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK-NF-kappaB pathway. J Leukoc Biol. 2007; 81: 1322-32.
5. Zhang H, Moochhala SM, Bhatia M. Endogenous hydrogen sulfide regulates inflammatory response by activating the ERK pathway in polymicrobial sepsis. J Immunol. 2008; 181: 4320-31.
6. Zhang H, Zhi L, Moore PK, et al. Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol. 2006; 290: L1193-201.
7. Bhatia M, Zhi L, Zhang H, et al. Role of substance P in hydrogen sulfide-induced pulmonary inflammation in mice. Am J Physiol Lung Cell Mol Physiol. 2006; 291: L896-904.
8. Li L, Bhatia M, Zhu YZ, et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 2005; 19: 1196-8.
9. Whiteman M, Haigh R, Tarr JM, et al. Detection of hydrogen sulfide in plasma and knee-joint synovial fluid from rheumatoid arthritis patients: relation to clinical and laboratory measures of inflammation. Ann N Y Acad Sci. 2010; 1203: 146-50.
10. Kloesch B, Liszt M, Broell J. H2S transiently blocks IL-6 expression in rheumatoid arthritic fibroblast-like synoviocytes and deactivates p44/42 mitogen-activated protein kinase. Cell Biol Int. 2010; 34: 477-84.
11. Whiteman M, Li L, Rose P, et al. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal. 2010; 12: 1147-54.
12. Andruski B, McCafferty DM, Ignacy T, et al. Leukocyte trafficking and pain behavioral responses to a hydrogen sulfide donor in acute monoarthritis. Am J Physiol Regul Integr Comp Physiol. 2008; 295: R814-20.
13. Caplan AI, Elyaderani M, Mochizuki Y, et al. Principles of cartilage repair and regeneration. Clin Orthop Relat Res. 1997: 254-69.
14. Yoo JU, Barthel TS, Nishimura K, et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am. 1998; 80: 1745-57.
15. Alsalameh S, Amin R, Gemba T, et al. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum. 2004; 50: 1522-32.
16. Marinova-Mutafchieva L, Taylor P, Funa K, et al. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum. 2000; 43: 2046-55.
17. Blanco FJ, Guitian R, Vazquez-Martul E, et al. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum. 1998; 41: 284-9.
18. Thomas CM, Whittles CE, Fuller CJ, et al. Variations in chondrocyte apoptosis may explain the increased prevalence of osteoarthritis in some joints. Rheumatol Int. 2010; doi: 10.1007/s00296-010-1471-9.
19. Kim HA, Song YW. Apoptotic chondrocyte death in rheumatoid arthritis. Arthritis Rheum. 1999; 42: 1528-37.
20. Saito S, Murakoshi K, Kotake S, et al. Granzyme B induces apoptosis of chondrocytes with natural killer cell-like cytotoxicity in rheumatoid arthritis. J Rheumatol. 2008; 35: 1932-43.
21. Polzer K, Schett G, Zwerina J. The lonely death: chondrocyte apoptosis in TNFinduced arthritis. Autoimmunity. 2007; 40: 333-6.
22. Liu H, Pope RM. The role of apoptosis in rheumatoid arthritis. Curr Opin Pharmacol. 2003; 3: 317-22.
23. Moodley D, Mody G, Patel N, et al. Mitochondrial depolarisation and oxidative stress in rheumatoid arthritis patients. Clin Biochem. 2010; 41: 1396-401.
24. Miesel R, Murphy MP, Kroger H. Enhanced mitochondrial radical production in patients which rheumatoid arthritis correlates with elevated levels of tumour necrosis factor alpha in plasma. Free Radic Res. 1996; 25: 161-9.
25. Blanco FJ, Rego I, Ruiz-Romero C. The role of mitochondria in osteoarthritis. Nat Rev Rheumatol. 2011; 7: 161-9.
26. Whiteman M, Armstrong JS, Cheung NS, et al. Peroxynitrite mediates calciumdependent mitochondrial dysfunction and cell death via activation of calpains. FASEB J. 2004; 18: 1395-7.
27. Thomas CM, Fuller CJ, Whittles CE, et al. Chondrocyte death by apoptosis is associated with cartilage matrix degradation. Osteoarthritis Cartilage. 2007; 15: 27-34.
28. Yatsugi N, Tsukazaki T, Osaki M, et al. Apoptosis of articular chondrocytes in rheumatoid arthritis and osteoarthritis: correlation of apoptosis with degree of cartilage destruction and expression of apoptosis-related proteins of p53 and c-myc. J Orthop Sci. 2000; 5: 150-6.
29. Cillero-Pastor B, Caramés B, Lires-Deán M, et al. Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis Rheum. 2008; 58: 2409-19.
30. Whiteman M, Spencer JP, Zhu YZ, et al. Peroxynitrite-modified collagen-II induces p38/ERK and NF-kappaB-dependent synthesis of prostaglandin E2 and nitric oxide in chondrogenically differentiated mesenchymal progenitor cells. Osteoarthritis Cartilage. 2006; 14: 460-70.
31. Whiteman M, Chu SH, Siau JL, et al. The pro-inflammatory oxidant hypochlorous acid induces Bax-dependent mitochondrial permeabilisation and cell death through AIF-/EndoG-dependent pathways. Cell Signal. 2007; 19: 705-14.
32. Schantz J-T, Ng KWA. Manual for primary human cell culture. Singapore: World Scientific; 2004. p. 23-46.
33. Li L, Salto-Tellez M, Tan CH, et al. GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Free Radic Biol Med. 2009; 47: 103-13.
34. Li L, Whiteman M, Guan YY, et al. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation. 2008; 117: 2351-60.
35. Sanchez C, Mateus MM, Defresne MP, et al. Metabolism of human articular chondrocytes cultured in alginate beads. Longterm effects of interleukin 1beta and nonsteroidal antiinflammatory drugs. J Rheumatol. 2002; 29: 772-82.
36. Legendre F, Bauge C, Roche R, et al. Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1beta-stimulated chondrocytes: study in hypoxic alginate bead cultures. Osteoarthritis Cartilage. 2008; 16: 105-14.
37. Armstrong JS, Whiteman M, Rose P, et al. The coenzyme Q10 analog decylubiquinone inhibits the redox-activated mitochondrial permeability transition: role of mitcohondrial [correction mitochondrial] complex III. J Biol Chem. 2003; 278: 49079-84.
38. Whiteman M, Rose P, Siau JL, et al. Hypochlorous acid-mediated mitochondrial dysfunction and apoptosis in human hepatoma HepG2 and human foetal liver cells: role of mitochondrial permeability transition. Free Radic Biol Med. 2005; 38: 1571-84.
39. Pattison DJ, Winyard PG. Dietary antioxidants in inflammatory arthritis: do they have any role in etiology or therapy? Nat Clin Pract Rheumatol. 2008; 4: 590-6.
40. Blanco FJ, Ochs RL, Schwarz H, et al. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol. 1995; 146: 75-85.
41. Asada S, Fukuda K, Nishisaka F, et al. Hydrogen peroxide induces apoptosis of chondrocytes: involvement of calcium ion and extracellular signal-regulated protein kinase. Inflamm Res. 2001; 50: 19-23.
42. Vaillancourt F, Fahmi H, Shi Q, et al. 4-Hydroxynonenal induces apoptosis in human osteoarthritic chondrocytes: the protective role of glutathione-S-transferase. Arthritis Res Ther. 2008; 10: R107.
43. Blanco FJ, Lopez-Armada MJ, Maneiro E. Mitochondrial dysfunction in osteoarthritis. Mitochondrion. 2004; 4: 715-28.
44. Whiteman M, Rose P, Siau JL, et al. Nitrite-mediated protection against hypochlorous acid-induced chondrocyte toxicity: a novel cytoprotective role of nitric oxide in the inflamed joint? Arthritis Rheum. 2003; 48: 3140-50.
45. Maneiro E, Lopez-Armada MJ, de Andres MC, et al. Effect of nitric oxide on mitochondrial respiratory activity of human articular chondrocytes. Ann Rheum Dis. 2005; 64: 388-95.
46. Whiteman M, Hooper DC, Scott GS, et al. Inhibition of hypochlorous acid-induced cellular toxicity by nitrite. Proc Natl Acad Sci U S A. 2002; 99: 12061-6.
47. Bamborough P, Morse MA, Ray KP. Targeting IKKbeta for the treatment of rheumatoid arthritis. Drug News Perspect. 2010; 23: 483-90.
48. Roman-Blas JA, Jimenez SA. Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis. Int Rev Immunol. 2008; 27: 351-74.
49. Coulthard LR, White DE, Jones DL, et al. p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol Med. 2009; 15: 369-79.
50. Thalhamer T, McGrath MA, Harnett MM. MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford). 2008; 47: 409-14.
51. Yang G, Yang W, Wu L, et al. H2S, endoplasmic reticulum stress, and apoptosis of insulin-secreting beta cells. J Biol Chem. 2007; 282: 16567-76.
52. Adhikari S, Bhatia M. H2S-induced pancreatic acinar cell apoptosis is mediated via JNK and p38 MAP kinase. J Cell Mol Med. 2008; 12: 1374-83.
53. Li W, Jin HF, Liu D, et al. Hydrogen sulfide induces apoptosis of pulmonary artery smooth muscle cell in rats with pulmonary hypertension induced by high pulmonary blood flow. Chin Med J (Engl). 2009; 122: 3032-8.
54. Zhang JH, Dong Z, Chu L. Hydrogen sulfide induces apoptosis in human periodontium cells. J Periodontal Res. 2010; 45: 71-8.
55. Yu F, Zhao J, Tang CS, et al. Effect of synthesized GYY4137, a slowly releasing hydrogen sulfide donor, on cell viability and distribution of hydrogen sulfide in mice. Beijing Da Xue Xue Bao. 2010; 42: 493-7.
56. Chiku T, Padovani D, Zhu W, et al. H2S biogenesis by human cystathionine gamma-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia. J Biol Chem. 2009; 284: 11601-12.
57. Singh S, Padovani D, Leslie RA, et al. Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions. J Biol Chem. 2009; 284: 22457-66.
58. Maneiro E, Martin MA, de Andres MC, et al. Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheum. 2003; 48: 700-8.
59. Takahashi T, Kitaoka K, Ogawa Y, et al. Lysosomal dysfunction on hydrogen peroxide-induced apoptosis of osteoarthritic chondrocytes. Int J Mol Med. 2004; 14: 197-200.
60. Beltowski J, Jamroz-Wisniewska A, Tokarzewska D. Hydrogen sulfide and its modulation in arterial hypertension and atherosclerosis. Cardiovasc Hematol Agents Med Chem. 2010; 8: 173-86.
61. Lazzerini PE, Capecchi PL, Bisogno S, et al. Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. Ann Rheum Dis. 2003; 62: 694-5.
62. Giustarini D, Lorenzini S, Rossi R, et al. Altered thiol pattern in plasma of subjects affected by rheumatoid arthritis. Clin Exp Rheumatol. 2005; 23: 205-12.
63. Bradley H, Waring RH, Emery P. Reduced thiol methyl transferase activity in red blood cell membranes from patients with rheumatoid arthritis. J Rheumatol. 1991; 18: 1787-9.
64. Sun Q, Collins R, Huang S, et al. Structural basis for the inhibition mechanism of human cystathionine gammalyase, an enzyme responsible for the production of H(2)S. J Biol Chem. 2009; 284: 3076-85.
65. Perry MM, Hui CK, Whiteman M, et al. Hydrogen sulfide inhibits proliferation and release of IL-8 from human airway smooth muscle cells. Am J Respir Cell Mol Biol. 2011; doi: 10.1165/rcmb.2010-0304OC.
66. Whiteman M, Li L, Kostetski I, et al. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulfide. Biochem Biophys Res Commun. 2006; 343: 303-10.
67. Whiteman M, Armstrong JS, Chu SH, et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J Neurochem. 2004; 90: 765-8.
68. Whiteman M, Cheung NS, Zhu YZ, et al. Hydrogen sulfide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem Biophys Res Commun. 2005; 326: 794-8.
69. Nagy P, Winterbourn CC. Rapid reaction of hydrogen sulfide with the neutrophil oxidant hypochlorous acid to generate polysulfides. Chem Res Toxicol. 2010; doi: 10.1021/tx100266a.
70. Tyagi N, Moshal KS, Sen U, et al. H2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid Redox Signal. 2009; 11: 25-33.
71. Muzaffar S, Shukla N, Bond M, et al. Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J Vasc Res. 2008; 45: 521-8.
72. Muellner MK, Schreier SM, Laggner H, et al. Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL. Biochem J. 2009; 420: 277-81.
73. Schreier SM, Muellner MK, Steinkellner H, et al. Hydrogen sulfide scavenges the cytotoxic lipid oxidation product 4-HNE. Neurotox Res. 2010; 17: 249-56.
74. Laggner H, Muellner MK, Schreier S, et al. Hydrogen sulfide: a novel physiological inhibitor of LDL atherogenic modification by HOCl. Free Radic Res. 2007; 41: 741-7.
75. Carballal S, Trujillo M, Cuevasanta E, et al. Reactivity of hydrogen sulfide with peroxynitrite and other oxidants of biological interest. Free Radic Biol Med. 2011; 50: 196-205.
76. Kimura Y, Dargusch R, Schubert D, et al. Hydrogen sulfide protects HT22 neuronalcells from oxidative stress. Antioxid Redox Signal. 2006; 8: 661-70.
77. Kimura Y, Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 2004; 18: 1165-7.
78. Calvert JW, Elston M, Nicholson CK, et al. Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemiainduced heart failure in mice. Circulation. 2010; 122: 11-9.
79. Calvert JW, Jha S, Gundewar S, et al. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res. 2009; 105: 365-74.
80. Kloesch B, Liszt M, Steiner G, et al. Inhibitors of p38 and ERK1/2 MAPkinase and hydrogen sulfide block constitutive and IL-1beta-induced IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2. Rheumatol Int. 2010; doi: 101007/s00296-010-1682-0.